Wegovy (semaglutide) Injection, 1 Mg/0.5 Ml, 4 Single-dose Prefilled Pens, Manufactured By: Novo Nordisk A/s, Dk-2880 Bagsvaerd, Denmark, Product Of Denmark, Novo Nordisk A/s, Novo Nordisk Inc., Plain

Wegovy Recall Summary Novo Nordisk is recalling Wegovy (semaglutide) 1 mg injection pens distributed nationwide because hair was found inside a prefilled syringe. This is a Class I recall, the most serious classification. The affected product is Wegovy 1 mg/0.5 mL in packages of 4 single-dose prefilled pens with NDC 0169-4501-14.

Recalling firm
Novo Nordisk Inc.
Product
Wegovy (semaglutide) Injection, 1 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-4501-14
Reason
Presence of Particulate Matter: Hair was found in a prefilled syringe
Classification
Class I
Category
drug recall
Country
United States
Agency
U.S. Food and Drug Administration
Recall date
2025-12-19
Status
Ongoing
Areas affected
AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
Distribution
Nationwide within the United States.

Official recall notice from U.S. Food and Drug Administration

Recall details on Nibble Recalls: https://trynibble.app/recalls/17b07de9-48a5-43af-8483-969ba0adc9e3